EGM
ORIC icon

Engineers Gate Manager’s Oric Pharmaceuticals ORIC Stock Holding History

Engineers Gate Manager’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,335
Closed -$84.5K – 2454
2025
Q4 		$84.5K Buy
+10,335
New +$119K ﹤0.01% 1937
2025
Q1 		– Sell
-16,554
Closed -$134K – 2459
2024
Q4 		$134K Buy
+16,554
New +$152K ﹤0.01% 1967
2022
Q3 		– Sell
-12,021
Closed -$54K – 1961
2022
Q2 		$54K Buy
+12,021
New +$48K ﹤0.01% 1785

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Engineers Gate Manager's ORIC Position: Q1 2026 in Review

Engineers Gate Manager sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 10,335 shares — an estimated $84.5K sold.

Engineers Gate Manager first reported a position in ORIC in Q2 2022 and held it in 3 quarters. The position peaked at $134K in Q4 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Engineers Gate Manager reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 10,335 Oric Pharmaceuticals shares in Q1 2026, an estimated $84.5K.
  • Engineers Gate Manager first reported a position in Oric Pharmaceuticals in Q2 2022 and held it in 3 quarters.
  • Engineers Gate Manager's Oric Pharmaceuticals position peaked at $134K in Q4 2024.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.